Stock Movers

On this episode of Stock Movers:
- GSK (GSK) agreed to buy Rapt Therapeutics (RAPT), a US-based biotech developing treatments for patients with inflammatory and immunologic diseases, in a deal valued at $2.2 billion. The UK drug company will pay $58 a share, equivalent to an equity value of $2.2 billion, according to a statement Tuesday. The price represents a premium of 65% compared with Rapt Therapeutics’ closing price of $35.10 on Monday.
- 3M (MMM) expects profit and sales to expand this year, signaling the company’s push to prioritize higher-growth markets and accelerate the introduction of new products will continue to lift its results.Adjusted earnings will be $8.50 to $8.70 a share in 2026, the maker of Post-it notes, roofing granules and electronics materials said Tuesday in a statement that also revealed better-than-expected quarterly results. Analysts had expected $8.64 on average, according to the average of estimates compiled by Bloomberg. Adjusted sales will climb about 4%, the company said.
- Homebuilder D.R. Horton (DHI) missed analysts’ estimates for quarterly home orders even as mortgage rates slid. The company reported 18,300 signed contracts for the three months through December, up 3% from a year earlier, according to a statement Tuesday. Analysts were expecting 18,653, the average in a survey compiled by Bloomberg.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- French luxury group LVMH is on track for a seventh straight session of losses, the longest streak since March, after US President Donald Trump signaled he could impose a 200% tariff on French wines and champagne.
- Ferretti’s second-largest investor is preparing to propose a shareholder vote to oust directors with connections to the yacht maker’s top owner, China’s Weichai Group, according to people familiar with the matter.
- GSK agreed to buy Rapt Therapeutics, a US-based biotech developing treatments for patients with inflammatory and immunologic diseases, in a deal valued at $2.2 billion.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- French luxury group LVMH is on track for a seventh straight session of losses, the longest streak since March, after US President Donald Trump signaled he could impose a 200% tariff on French wines and champagne.
- Shares of Wise Plc jumped the most in more than seven months after the money-transfer firm gave an upbeat earnings guidance and said it’s on track to shift its primary listing to the US in the first half of this year.
- Italy’s Finance Ministry is backing Banca Monte dei Paschi di Siena SpA Chief Executive Officer Luigi Lovaglio for a new term in the role, according to people familiar with the matter.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Bayer’s shares surged after the US Supreme Court said it would hear the company’s appeal in a Roundup case that could undercut thousands of lawsuits tied to the weedkiller.

- Workspace, a landlord that rents space on flexible terms to mostly small- and medium-sized London businesses, is shaking up its top management after a period of turbulence saw shares drop for two consecutive years.

- BMW and other european automakers plunged after US President Donald Trump threatened to hike tariffs again in the standoff over Greenland.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Bayer’s shares surged after the US Supreme Court said it would hear the company’s appeal in a Roundup case that could undercut thousands of lawsuits tied to the weedkiller.
- BMW and other european automakers plunged after US President Donald Trump threatened to hike tariffs again in the standoff over Greenland.
- LVMH drops as much as 4.8%, and is among the weakest members of the Stoxx 600 consumer products and services index on Monday, as Morgan Stanley downgrades to equal-weight, citing a “pause for breath”.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers, we take a look at some of the week's biggest gainers and decliners:

- Moderna (MRNA) saw it shares surge over the week. On Tuesday, it closed up 17%, marking its best day since December 2022. At the week's close, Arbutus Biopharma got one of its patent revoked by the European Patent Office, which is likely to affect its case against Moderna. Pharmaceutical companies traded higher broadly through the week.

- Constellation Energy (CEG), as well as other independent power producers saw shares declined by the week's end after the Trump administration and several states laid out a plan intended to compel technology companies to effectively fund the construction of new power plants as a way to tame surging consumer utility bills while aiding the development of data centers. Shares of the largest independent power producers slid. Vistra Corp. declined as much at 9.5%, Talen Energy Corp. slipped as much as 11% and Constellation Energy Corp. dropped as much as 10%.

- Used-card retailer Carmax (KMX) and Carvana (CVNA) have seen a strong start to 2026 as investors buy the November dip, and tracking data shows unit sales trending higher year-over-year, according to Barclays analyst John Babcock.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers: 

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.

- Morgan Stanley laid out its bullish case for why investors should buy ASML Holding NV (ASML) shares, saying in the most optimistic scenario the stock has a 70% rally ahead as chipmakers ramp up spending to meet soaring demand for artificial intelligence. The Dutch semiconductor equipment maker is one of the bank’s top stock picks. Morgan Stanley analysts said they’re even more positive after Taiwan Semiconductor Manufacturing Co., ASML’s biggest client, showed the AI spending boom isn’t slowing down. ASML shares are up 25% so far in 2026, marking a roaring start to the year. 

- ImmunityBio (IBRX) shares advanced for a 11th straight session — a record streak after the company gave efficacy results from a clinical cancer trial. The stock is also on pace for its biggest weekly gain since October 2023 and its best month since December 2019.

- Constellation Energy (CEG) as well as other independent power producers saw shares decline after the Trump administration and several states laid out a plan intended to compel technology companies to effectively fund the construction of new power plants as a way to tame surging consumer utility bills while aiding the development of data centers. Shares of the largest independent power producers slid. Vistra Corp. declined as much at 9.5%, Talen Energy Corp. slipped as much as 11% and Constellation Energy Corp. dropped as much as 10%.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Constellation Energy (CEG) shares are dropping after the Trump administration and several states laid out a plan intended to compel technology companies to effectively fund the construction of new power plants as a way to tame surging consumer utility bills while aiding the development of data centers. The unprecedented plan has two ambitious goals: First, it aims to accelerate the construction of new power plants — specifically those capable of providing round-the-clock power like natural gas — needed to supply data centers that are crucial to the artificial intelligence boom. And second, it seeks to address growing tensions over who will bear the costs of rising electricity demand as consumers face higher utility bills. Shares of the largest independent power producers slid. Vistra Corp. declined as much at 9.5%, Talen Energy Corp. slipped as much as 11% and Constellation Energy Corp. dropped as much as 10%.

- GE Vernova (GEV) traded higher on the major energy shakeup. Jeffries analyst Julien Dumoulin-Smith sees GE Vernova as the clearest winner from these plans as PJM transmission and distribution companies will have less pressure on bills and potential regulated distribution. Shares of the company rose over 7%. 

- Freddie Mac (FMCC) and Fannie Mae (FNMA) shares are on an extended days-long losing streaks after Federal Housing Finance Agency Director Bill Pulte cheered President Trump’s decision not to sell the mortgage-finance companies during his first term. Earlier this week, shares of both mortgage-finance giants sunk to their lowest levels since late November as investors continued to assess the impact of a slew of economic proposals from President Trump that are linked to housing.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- PNC Financial (PNC) shares rose to a four-year high after the regional bank reported a 9% increase in fourth-quarter revenue, beating analysts’ estimates. Non-interest income in the fourth quarter was up 14% to $2.34 billion, driven by fees from the capital-markets and advisory business, which surged 41% to $489 million.
-GE Vernova (GEV) shares are up after President Donald Trump and US Northeastern state governors agreed to push for an emergency wholesale electricity auction to compel technology companies to fund new power plants.
-HP (HPQ) shares fall after Barclays downgraded the PC company to underweight from equal-weight. “Secular challenges across both PCs and Printing, combined with a lack of catalyst, will cause the stock to remain pressured in 2026,” writes analyst Timothy Long.

See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- AST SpaceMobile (ASTS) shares soar the most since December and enough to reach an intraday record, after the satellite internet company was given prime contract position for the US Missile Defense Agency’s SHIELD program, which is connected to Donald Trump’s Golden Dome effort.
- PNC Financial (PNC) shares rise after the regional bank forecasted net interest income growth for 2026 of about +14%. It also reported revenue that came in above the average analysts estimates.
- Vistra (VST) shares dropped to push for an emergency wholesale electricity auction to compel technology companies to fund new power plants.

See omnystudio.com/listener for privacy information.